alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



Exhibit 31.1 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Allan Griebenow, certify that:  1.
    
    I have reviewed this quarterly report on Form 10-QSB of Axcess
International, Inc.;2.
    
    Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this quarterly report;3.
    
    Based on my knowledge, the financial statements, and other
financial information included in this quarterly report, fairly present
in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented
in this quarterly report;4.
    
    The registrants other certifying officers and I are responsible
for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rule 13a-14 and 15d-14) for the registrant and
we have:  a)
    
    designed such disclosure controls and procedures to
ensure that material information relating to the registrant,
including its consolidating subsidiaries, is made known to us by
others within those entities, particularly during the period in
which this quarterly report was prepared;b)
    
    evaluated the effectiveness of the registrants
disclosure controls and procedures as of the end of the period
covered by this quarterly report (the Evaluation Date); andc)
    
    presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures
based on the required evaluation as of the Evaluation Date;  5.
    
    The registrants other certifying officers and I have disclosed,
based on our most recent evaluation, to the registrants auditors and
the audit committee of registrants board of directors (or persons
performing the equivalent function):  a)
    
    all significant deficiencies in the design or operation
of internal controls which could adversely affect the
registrants ability to record, process, summarize and report
financial data and have identified for the registrants auditors
any material weaknesses in internal controls; andb)
    
    any fraud, whether or not material, that involves
management or other employees who have a significant role in the
registrants internal controls; and  6.
    
    The registrants other certifying officers and I have indicated in
this quarterly report whether or not there were significant changes in
internal controls or in other factors that could significantly affect
internal controls subsequent to the date of our most recent evaluation,
including any corrective actions with regard to significant
deficiencies and material weaknesses. Date: November 9, 2004 /s/ ALLAN GRIEBENOW
M.C.N., petitioner, v. K.D.F.

No. 12-954.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the Superior Court of Pennsylvania, Philadelphia Office, denied.
Daniel J. BERNAL, Jr. v. CRESCENT FOUNDATIONS, LLC and Paul C. Austin

NO. 2019-C-0635

Supreme Court of Louisiana.

June 17, 2019

Denied.
[Federal Register Volume 60, Number 92 (Friday, May 12, 1995)]
[Notices]
[Page 25732]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11699]



-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR
[OR-942-00-1420-00: G5-115]


Filing of Plats of Survey: Oregon/Washington

AGENCY: Bureau of Land Management.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The plats of survey of the following described lands are 
scheduled to be officially filed in the Oregon State Office, Portland, 
Oregon, thirty (30) calendar days from the date of this publication.

Willamette Meridian

Oregon

T. 37 S., R. 2 E., accepted March 28, 1995
T. 38 S., R. 4 E., accepted March 17, 1995
T. 15 S., R. 1 W., accepted March 7, 1995
T. 17 S., R. 2 W., accepted April 28, 1995
T. 36 S., R. 5 W., accepted March 3, 1995
T. 10 S., R. 10 W., accepted April 11, 1995 (2 Sheets)
T. 18 S., R. 12 W., accepted April 11, 1995

Washington

T. 16 N., R. 19 E., accepted March 30, 1995

    If protests against a survey, as shown on any of the above plat(s), 
are received prior to the date of official filing, the filing will be 
stayed pending consideration of the protest(s). A plat will not be 
officially filed until the day after all protests have been dismissed 
and become final or appeals from the dismissal affirmed.
    The plat(s) will be placed in the open files of the Oregon State 
Office, Bureau of Land Management, 1515 S.W. 5th Avenue, Portland, 
Oregon 97201, and will be available to the public as a matter of 
information only. Copies of the plat(s) may be obtained from the above 
office upon required payment. A person or party who wishes to protest 
against a survey must file with the State Director, Bureau of Land 
Management, Portland, Oregon, a notice that they wish to protest prior 
to the proposed official filing date given above. A statement of 
reasons for a protest may be filed with the notice of protest to the 
State Director, or the statement of reasons must be filed with the 
State Director within thirty (30) days after the proposed official 
filing date.
    The above-listed plats represent dependent resurveys, survey and 
subdivision.

FOR FURTHER INFORMATION CONTACT: Bureau of Land Management, (1515 S.W. 
5th Avenue,) P.O. Box 2965, Portland, Oregon 97208.

    Dated: May 3, 1995.
Robert D. DeViney, Jr.,
Acting Chief, Branch of Realty and Records Services.
[FR Doc. 95-11699 Filed 5-11-95; 8:45 am]
BILLING CODE 4310-33-M
In re Brian William SCHUMAKER, petitioner.

No. 12-9876.

Supreme Court of the United States

May 28, 2013.

Petition for writ of habeas corpus denied.
Supplementary
Agreement to

    The
House Property Transfer Contract

    Dated
January 15, 2007

     

    Party A:
Tianjin Mengyang Biotechnology Co., Ltd.

    Business
License No.: 120223000009884

    Address:
Jinhai Road, Jinghai Economic Development Area,
Tianjin  301600

    Tel:
022-27984733

    


    Party B:
Tianjin Yayi Industrial Co., Ltd.

    Business
License No.: 120193000003231

    Address:
Unit C, 4th floor,
D1 Building, Xinmao Technology Park, Huayuan

    Industrial
Park Area, Tianjin  300384

    Tel:022-27984058

     

    Since
party A and B had signed the Plant Transfer Contract on January 15, 2007, both
parties have negotiated and achieved the following agreement on the above
mentioned Plant Transfer Contract on the basis of the relevant laws and
regulations of the People’s Republic of China:

     

    
      A.
Time
Limit for Transferring the House Property

       

    

    Since the
construction of four-stories office building was stopped during the Beijing
Olympic Games under the requirement of the local government of Tianjin, and
considering that the winter season is drawing near right after the end of the
Olympic Games, party A and B have negotiated and agreed that the time limit for
transferring the house property should be extended from September 30, 2008 to
May 31, 2009. The related time limit will be subject to this Supplementary
Agreement.

    


    
      
         

      

      
         

        
          

        

      

      
         

      

       

    

    
      B.
Responsibilities
for Breaching

       

    

    Both
party A and B regard the forces which had led to the delay of the above
mentioned time limit as irresistible forces. Therefore, neither party would
request the other to undertake the responsibilities for breaching stated in the
House Property Transfer Contract.

    


    C. Other
clauses remain the same as the above mentioned House Property Transfer
Contract.

     

    The
agreement should be in duplicate, with each of party A and B holding one
original copy.

     

    The
agreement is valid after both parties have stamped or signed on it。

    


    
      
        	
                Party
      A (stamp): _________________

              	
                Party
      B (stamp): __________________

              
	
                Signature:
      _______________

              	
                Signature:
      ______________

              
	
                Date:
      October 12, 2008

              	
                Date:
      October 12, 2008
II 

109TH CONGRESS 

1ST SESSION H. R. 1270 

IN THE SENATE OF THE UNITED STATES 

MARCH 17, 2005 

Received 

AN ACT 

To amend the Internal Revenue Code of 1986 to extend 

the Leaking Underground Storage Tank Trust Fund 

financing rate. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

HR 1270 RDS 

1 SECTION 1. EXTENSION OF LEAKING UNDERGROUND STOR2 AGE TANK TRUST FUND FINANCING RATE. 

3 (a) IN GENERAL.—Paragraph (3) of section 4081(d) 

4 of the Internal Revenue Code of 1986 (relating to Leaking 

5 Underground Storage Tank Trust Fund financing rate) 

6 is amended by striking ‘‘April 1, 2005’’ and inserting ‘‘Oc7 tober 1, 2005’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 this section shall take effect on the date of the enactment 

10 of this Act. 

Passed the House of Representatives March 16, 

2005. 

Attest: JEFF TRANDAHL, 

Clerk.
了解您的

护肤产品中含有什么成分

了解更多信息

www.fda.gov/healthequity

healthequity@fda.hhs.gov

1-888-INFO-FDA

(1-888-463-6332)

@FDAHealthEquity









可通过浏览 

www.fda.gov/SkinFacts来找到Get 

the Skin Facts! (获取关于护肤产品的

情况说明书),了解护肤产品安全方面的

知识。

如果您在使用护肤产品时出现不良反应,

请联系您的医疗服务提供者,并将事件报

告给FDA,可在这个网页

www.fda.gov/medwatch/report.htm

进行报告,也可打电话 

1-800-fda-1088 进行报告。

您知道

吗?

务必要查阅护肤产品的标签,看其

是否含有可能对健康构成风险的成

分。要避免使用贴有手工标签、非

英语标签或根本没有标签的产品。

这样的产品违反了 FDA 的规定,

可能是有害的。

FDA 少数族裔健康和健

康平等办公室
什么是皮肤美白产品?

“皮肤美白”是用来说明市场上的那些用来淡化皮

肤色素沉着(颜色)的产品的用词。其他一些名称可

能包括:

• 皮肤光亮剂或美白剂

• 皮肤漂白剂 

• 肤色均匀剂 

• 祛斑剂

• 褪色霜

• 化学换肤剂

皮肤美白产品的广告通常宣传其可以治疗各种皮肤

状况,如皮肤变色/色素沉着(黄褐斑)、老人斑或

黑斑、雀斑、粉刺和皱纹。

对苯二酚有何健康风险?

FDA 曾收到在使用含有对苯二酚的皮肤美白产品后

出现严重副作用的报告,包括皮疹、面部肿胀和永

久性皮肤变色(褐黄病)。

汞的健康风险是什么? 

汞是一种剧毒金属,会损害神经系统、消化系统和

免疫系统以及肺、肾、皮肤和眼睛。即使不使用该

产品的其他家庭成员,也可能通过吸入空气中的汞

蒸气或接触受汞污染的表面而接触到汞。汞对发育

中的幼儿的大脑和神经系统尤其有害。 

汞中毒的症状包括易怒、颤抖、视力或听力改变、

记忆问题、抑郁、手脚或嘴巴周围麻木和刺痛。 

汞中毒还可能导致昏迷甚至死亡。

FDA 正在采取什么措施来保护公众

免受皮肤美白产品中的这些成分的

危害? 

含有对苯二酚或汞的皮肤美白产品的非处方销售是

非法的。FDA 可以对以非处方的方式销售这些产品

的任何人采取行动。 

您可以从您的医疗服务提供者那里获得含有对苯二

酚的处方护肤产品。FDA 允许在没有安全有效的替

代品的情况下在某些化妆品中作为防腐剂而使用极

少量的汞。然而,在任何皮肤美白化妆品中使用汞

都是被禁止的。

购买非处方美白产品时,我应该注

意什么? 

应查阅其产品标签,看看它是否含有对苯二酚或

汞。联邦法律要求在美国销售的任何化妆品或非处

方(OTC)产品的标签上都要列出其成分。请注意,

汞在产品标签上可能被列为氯化亚汞、甘汞、水银

汞或Hg 等等。

一些含有对苯二酚或汞的非法皮肤美白产品可能并

没有在标签上列出这些成分。要避免使用那些贴有

手工标签、非英语标签或根本没有标签的产品。这

样的产品违反了 FDA 的规定,可能是有害的。

如果您出现任何汞中毒症状,请拨打毒物控

制中心,电话是 1-(800)-222-1222,

并立即联系您的医疗服务提供者。

美白产品中是

否含有有害 成

分?

 

在以霜剂、乳液、肥皂或粉末形式出售的非法皮肤

美白产品中,有时会发现对苯二酚和汞。当您在皮

肤上使用这些成分时,它们会被您的身体吸收,持

续使用会让它们在体内积累,并可能会造成伤害。
James Arthur LEE Appellant, v. State of Florida, DEPARTMENT OF CORRECTIONS, Appellee.

No. 3D19-389

District Court of Appeal of Florida, Third District.

Opinion filed May 1, 2019

James Arthur Lee, in proper person.

Ashley Moody, Attorney General, for appellee.

Before EMAS, C.J., and LOGUE and HENDON, JJ.

PER CURIAM.

James Arthur Lee filed a notice of appeal from the trial court's order denying his petition for writ of mandamus. On March 6, 2019, we dismissed this appeal because, by previous order entered by this Court in case number 3D03-1393, James Arthur Lee was prohibited from filing any pro se appeals or petitions related to his conviction and sentence (or related to his prisoner status resulting from his conviction and sentence) in lower tribunal case number 96-6742.1 We further directed Lee to show cause why he should not be sanctioned for violating this Court's order in 3D03-1393 by continuing to file pro se pleadings with this Court related to lower tribunal case number 96-6742.

Lee has filed a document which we treat as his response to the show cause order. Following our review, we conclude that James Arthur Lee has failed to show cause why he should not be sanctioned for violating this Court's order in 3D03-1393, by continuing to file pro se pleadings with this Court related to lower tribunal case number 96-6742. We further note that appellant previously attempted to file pro se pleadings in 3D17-1231, resulting in a similar dismissal order.

We prohibit James Arthur Lee from filing any pro se pleading or paper with this Court related to lower tribunal case number 96-6742, or related to his prisoner status resulting from his conviction and sentence in case number 96-6742. We hereby direct the Clerk of this Court to refuse to accept any such pleading or paper relating to lower tribunal case number 96-6742 unless it has been reviewed and signed by *688an attorney who is a duly licensed member of The Florida Bar in good standing.

Additionally, we direct the Clerk of this Court to forward a copy of this order to the Florida Department of Corrections for its consideration of disciplinary action, including the forfeiture of gain time. *See* § 944.279(1), Fla. Stat. (2018).

1

Case number 96-6742 is Lee's conviction and sentence and case number 18-35897 is Lee's pro se petition for writ of mandamus, filed with the circuit court (and assigned a separate case number) seeking the issuance of a writ of mandamus directed to the Florida Department of Corrections, arising out of and related to Lee's incarcerative status following his conviction and sentence in 96-6742.
Exhibit 15(b)


Texas Utilities Electric Company:

We have made a review, in accordance with standards established by the
American Institute of Certified Public Accountants, of the unaudited condensed
consolidated interim financial information of Texas Utilities Electric Company
and subsidiaries ("TU Electric") for the periods ended March 31, 1999 and
1998, as indicated in our report dated May 13, 1999; because we did not
perform an audit, we expressed no opinion on that information.

We are aware that our report referred to above, which is included in TU
Electric's Quarterly Report on Form 10-Q for the quarter ended March 31, 1999,
is incorporated by reference in Registration Statements No. 33-69554 and
333-42985 on Form S-3, and Registration Statement No. 33-83976, as amended by
Post Effective Amendment No.1 to Form S-3, of Texas Utilities Electric
Company.

We also are aware that the aforementioned report, pursuant to Rule 436(c)
under the Securities Act of 1933, is not considered a part of the Registration
Statement prepared or certified by an accountant or a report  prepared or
certified by an accountant within the meaning of Sections 7 and 11 of that
Act.


DELOITTE & TOUCHE LLP

Dallas, Texas
May 13, 1999
[Federal Register Volume 60, Number 85 (Wednesday, May 3, 1995)]
[Notices]
[Page 21825]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10899]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration (SAMHSA)


Correction of Meeting Notices

    Public notice was given in the Federal Register on April 18, 1995, 
Vol. 60, No. 74, page 19405, that the Substance Abuse and Mental Health 
Services Administration (SAMHSA) National Advisory Council meeting on 
May 15, 1995, would be open from 9:00 a.m. to 3:00 p.m. and closed for 
review of contract proposals from 3:15 p.m. to 6:00 p.m. Due to 
unforeseen circumstances, the meeting schedule has been revised. The 
closed session is now scheduled from 9:00 a.m. to 10:30 a.m., and the 
open session will be from 10:45 a.m. until adjournment. In addition, a 
status report from the Council's AIDS workgroup will not be presented 
at this meeting.
    Public notice was also given in the Federal Register on April 19, 
1995, Vol. 60, No. 75, page 19602, that the Center for Substance Abuse 
Prevention (CSAP) National Advisory Council would be meeting on May 25 
and 26, 1995. However, the meeting will now be held for only one day, 
May 25.

    Dated: April 27, 1995.
Jeri Lipov,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 95-10899 Filed 5-2-95; 8:45 am]
BILLING CODE 4162-20-P
Lorenzo WILSON, petitioner, v. ILLINOIS.

No. 12-1002.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the Appellate Court of Illinois, First District, denied.
Order entered November 2 4 , 2014

In The 

## Court of Appeals **Fifth District of Texas at Dallas**

No. 05

- 14

- 00353

- CV

MRC PERMIAN COMPANY AND JOE FORAN, Appellant s

V.

THREE RIVERS OPERATI NG COMPANY AND THREE RIVERS ACQUISITION LLC, Appellee s

On Appeal from the 14th Judicial District Court Dallas County, Texas
Trial Court Cause No. DC

- 12

- 12637

- A



### O RDER

W e GRANT appellants’ November 20, 2014 unopposed motion for extension of time to

file reply brief and ORDER the brief be fil ed no later than January 2, 2015

.

/s/ CRAIG STODDART

JUSTICE
#### Narinder KAUR, Petitioner, v. John ASHCROFT, Attorney General, Respondent.

No. 03-70541.

United States Court of Appeals, Ninth Circuit.

Argued and Submitted April 14, 2004.

Decided April 27, 2004.

Earle A. Sylva, Esq., George T. Heridis, Esq., Tsz-Hai Huang, Hardeep S. Rai, Earle A. Sylva, Tsz-Hai Huang, Rai & Assoc., San Francisco, CA, for Petitioner.

Regional Counsel, Western Region Immigration & Naturalization Service, Laguna Niguel, CA, Ronald E. LeFevre, Chief Legal Officer, Office of the District Counsel, Department of Homeland Security, San Francisco, CA, Papú Sandhu, Isaac R. Campbell, Esq., U.S. Department of Justice, Civil Div./Office of Immigration Lit., Washington, DC, for Respondent.

Before: WALLACE, KOZINSKI, and THOMAS, Circuit Judges.

MEMORANDUM *

Narinder Kaur petitions for review from the Board of Immigration Appeal’s summary affirmance of an immigration judge’s (“IJ”) denial of her application for asylum and withholding of removal. We deny the petition for review.

The IJ denied Kaur’s application because she found her to be not credible, and found the additional documentary evidence submitted by Kaur insufficient to independently establish her eligibility for asylum or withholding of removal. We review credibility findings by an IJ for substantial evidence. *Chebchoub v. INS,*257 F.3d 1038, 1043 (9th Cir.2001). Although some of the adverse credibility findings may be of questionable significance, we conclude that substantial evidence supports the IJ’s adverse credibility determination. Of particular significance were the discrepancies concerning the time and details of her arrest. Because these discrepancies were not minor, and relate to the basis for the applicant’s alleged fear of persecution, going to “the heart of the asylum claim,” they are sufficient to sustain the IJ’s adverse credibility finding. *Malhi v. INS,*336 F.3d 989, 993 (9th Cir.2003).

PETITION DENIED.

*

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
Case 3:17-cr-00093-WHA Document 22 Filed 02/16/17 Page 1 of 7
Case 3:17-cr-00093-WHA Document 22 Filed 02/16/17 Page 2 of 7
Case 3:17-cr-00093-WHA Document 22 Filed 02/16/17 Page 3 of 7
Case 3:17-cr-00093-WHA Document 22 Filed 02/16/17 Page 4 of 7
Case 3:17-cr-00093-WHA Document 22 Filed 02/16/17 Page 5 of 7
Case 3:17-cr-00093-WHA Document 22 Filed 02/16/17 Page 6 of 7
Case 3:17-cr-00093-WHA Document 22 Filed 02/16/17 Page 7 of 7
Paano

 matutukoy at matutugunan ang

NATIN

 MALING IMPORMASYON

Panatilihing ligtas ang 

iyong sarili kasama ang 

iyong pamilya, mga 

kaibigan, at komunidad 

sa pamamagitan 

ng pagkilala at 

pagtugon sa maling 

impormasyon. Ano ang ibig naming sabihin 

sa ‘maling impormasyon’? 

Ito’y impormasyon na, sinasadya at hindi 

sinasadyang pinakakalat, mali, hindi tumpak, o 

mapanlinlang alinsunod sa pinakamahusay na 

makukuhang ebidensya sa panahong iyon. 

Paano ko matutukoy ang 

maling impormasyon?

● Siyasatin ang pinagmulan. At kumpirmahin sa 

maaasahang pinagmumulan ng impormasyon.

● Unawain nang higit pa kaysa basahin lamang ang 

paulong-balita upang makuha ang buong konteksto.

● Unawain ang layunin sa likod ng post.

Bakit mabilis kumalat ang maling impormasyon? 

● Nais nating protektahan ang mga taong may malasakit tayo.

● Nais nating maramdamang konektado tayo.

● Nais nating maramdamang mayroon tayong bagong impormasyong hindi alam 

ng iba.

● Maaaring naghahanap tayo ng mga paliwanag o nagnanais na magbahagi ng 

impormasyon na nakakatulong sa ating maunawaan ang mga kaganapan.

● Madalas na pumupukaw ng emosyonal na tugon ang maling impormasyon.

● Sa simula ay maaaring lumabas na makatotohanan ang maling impormasyon 

kapag wala ito sa konteksto.

● Dahil sa mga salik na ito, ang mga gumagamit ay maaaring magpalaganap ng 

maling impormasyon nang mas mabilis kaysa sa katotohanan sa social media.

● Ang lahat ng tao, eksperto man o hindi, ay may pantay na boses sa internet.
Bakit nakakapinsala ang maling impormasyon?

Kapag naniniwala ang mga tao, at kumikilos nang alinsunod sa, 

maling impormasyon nagdurusa ang kalusugan ng publiko.

Ano ang maaari kong gawin kapag nakakarinig 

o nakakakita ako ng maling impormasyon? 

Tumulong sa pagpigil ng pagkalat ng maling impormasyon sa pamamagitan ng paggawa ng 

tatlong bagay:

● Tukuyin ang maling impormasyon.

● Huwag makibahagi sa pagpapakalat ng maling impormasyon.

● Idirekta ang mga tao sa impormasyong pangkalusugan mula sa mga pinagkakatiwalaang 

pinagmumulan tulad ng FDA at mga katuwang ng ating pamahalaan, kabilang ang usa.gov/

health, coronavirus.gov at vaccines.gov.

Paano ako epektibong makikipag-usap sa mga kaibigan 

at pamilya tungkol sa maling impormasyon? 

Kapag nakikipag-usap sa mga tao, siguraduhing ikaw ay: 

● Nakikinig ● Hindi nanghihiya

● May empatiya ● Gumagamit ng ingklusibong wika

● Tumutukoy sa mga maaasahang 

pinagmumulan ng impormasyon

Isaalang-alang ang pagbabahagi ng mga puntos na ito:

● Ayon sa katangian nito, idinisenyo ang siyensya para magbago.

● Maaaring magbago ang aming mga rekomendasyon, habang nagbabago ang siyensya.

● Hindi iyon nangangahulugan na hindi natin dapat pagkatiwalaan ang siyensya. Ang 

pagbabago sa siyensya ay resulta ng isang mas malalim na pang-unawa sa paksa.

● Magtiwala sa siyensya. Nagbibigay ito sa atin ng ilan sa pinakamagagaling na medikal 

na tagumpay ng sangkatauhan tulad ng pagwawakas ng smallpox (sa pamamagitan ng 

pagbabakuna), germ theory (ginawang mas ligtas ang mga operasyon),at gene therapy 

(pinagagaling ang mga partikular na uri ng pagkabulag).
Did you know? 

All mammography facilities 

in the U.S. must be certified. 

Find a certified facility in your area: 

www.fda.gov/findmammography